The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 29, 2019

Filed:

Apr. 16, 2015
Applicants:

Inserm (Institut National DE LA Santé ET DE LA Recherche Médicale), Paris, FR;

Université DE Bordeaux, Bordeaux, FR;

Université DE Rennes, Rennes, FR;

Ecole Des Hautes Etudes En Santé Publique (Ehesp), Rennes, FR;

Université Des Antilles ET DE LA Guyane, Pointe-à-Pitre, FR;

Institut Bergonié, Bordeaux, FR;

University of Nottingham, Nottingham, GB;

Inventors:

Patrick Legembre, Rennes, FR;

Pierre Vacher, Bordeaux, FR;

Doriane Sanseau, Rennes, FR;

Aubin Penna, Rennes, FR;

Robin Flynn, Sutton Bonington Leicestershire, GB;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/70 (2006.01); C07K 16/00 (2006.01); C07K 14/705 (2006.01); C07K 14/525 (2006.01); G01N 33/68 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/70575 (2013.01); C07K 14/525 (2013.01); C07K 16/00 (2013.01); G01N 33/6872 (2013.01); A61K 38/00 (2013.01); C07K 2319/74 (2013.01); G01N 2333/70575 (2013.01); G01N 2333/70578 (2013.01); G01N 2500/02 (2013.01);
Abstract

The present invention relates to polypeptides and uses thereof for reducing CD95-meditated cell motility. In particular, the present invention relates to a polypeptide having an amino acid sequence having at least 70% of identity with the amino acid sequence ranging from the amino-acid residue at position 175 to the amino-acid residue at position 191 in SEQ ID NO:1.


Find Patent Forward Citations

Loading…